Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study team propose to develop a database and biorepository of Asian female never smokers. This population is at increased risk for developing lung cancer but do not meet current lung cancer screening criteria. Study procedures will include up to 3 low-dose CT (LDCT) scans and a blood-based assay with the capability for early detection of cancer. Clinical, demographic and exposure history including possible WTC exposure will also be collected.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants who inquire about the program and are eligible to proceed with the Low Dose Computed Tomography (LDCT) screening test | Screening (Day -28 to -1) | |
| Number of Participants who undergo initial LDCT | Visit 2 (Day 30 +/- 7) |
| Measure | Description | Time Frame |
|---|---|---|
| Number of diagnoses of lung cancer | Visit 2 (Day 30 +/- 7) | |
| Number of diagnoses of lung cancer | Visit 4 (Day 365 +/- 14) | |
| Number of diagnoses of lung cancer |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Women of Asian/Asian continent ancestry and ethnic groups are eligible for this trial.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elaine Shum, MD | NYU Langone Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | United States |
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) upon reasonable request.
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to FANSS@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Not provided
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Serial specimens of blood will be collected at the initial screen from each subject. In addition, paraffin blocks from resected lung tumors from any subject who have any pathological specimens from the lung will be collected retrospectively.
| Visit 6 (day 730 +/- 14) |
| Detection rate of Incidental thyroid nodules | Visit 2 (Day 30 +/- 7) |
| Detection rate of Incidental thyroid nodules | Visit 4 (Day 365 +/- 14) |
| Detection rate of Incidental thyroid nodules | Visit 6 (day 730 +/- 14) |
| Detection rate of Incidental coronary artery disease | Visit 2 (Day 30 +/- 7) |
| Detection rate of Incidental coronary artery disease | Visit 4 (Day 365 +/- 14) |
| Detection rate of Incidental coronary artery disease | Visit 6 (day 730 +/- 14) |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |